BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17106239)

  • 1. Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites.
    Bindra RS; Glazer PM
    Cancer Biol Ther; 2006 Oct; 5(10):1400-7. PubMed ID: 17106239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.
    Bindra RS; Gibson SL; Meng A; Westermark U; Jasin M; Pierce AJ; Bristow RG; Classon MK; Glazer PM
    Cancer Res; 2005 Dec; 65(24):11597-604. PubMed ID: 16357170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia.
    Bindra RS; Glazer PM
    Oncogene; 2007 Mar; 26(14):2048-57. PubMed ID: 17001309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells.
    Hu XT
    Biochem Biophys Res Commun; 2008 May; 369(2):277-80. PubMed ID: 18294958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
    Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualizing dynamic E2F-mediated repression in vivo.
    Agromayor M; Wloga E; Naglieri B; Abrashkin J; Verma K; Yamasaki L
    Mol Cell Biol; 2006 Jun; 26(12):4448-61. PubMed ID: 16738312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2Fs link the control of G1/S and G2/M transcription.
    Zhu W; Giangrande PH; Nevins JR
    EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q; Li J; Cenkci B; Kretzner L
    Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase.
    Fernández de Mattos S; Lam EW; Tauler A
    Biochem J; 2002 Nov; 368(Pt 1):283-91. PubMed ID: 12139485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.
    Burkhart DL; Wirt SE; Zmoos AF; Kareta MS; Sage J
    PLoS Genet; 2010 Jun; 6(6):e1001003. PubMed ID: 20585628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RB family tumor suppressor activity may not relate to active silencing of E2F target genes.
    Vormer TL; Wojciechowicz K; Dekker M; de Vries S; van der Wal A; Delzenne-Goette E; Naik SH; Song JY; Dannenberg JH; Hansen JB; Te Riele H
    Cancer Res; 2014 Sep; 74(18):5266-76. PubMed ID: 25056122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activities of E2F family members: unique functions in regulating transcription.
    Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
    Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.